NeutriSci International Inc Market Cap ($892.12K)
Market Cap & Net Worth: NeutriSci International Inc (NU)
NeutriSci International Inc market cap. NeutriSci International Inc (V:NU) has a market capitalization of $892.12K (CA$1.23 Million) as of November 1, 2026. Listed on the V stock exchange, this Canada-based company holds position #30765 globally and #1590 in its home market, demonstrating a -25.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NeutriSci International Inc's stock price CA$11.61 by its total outstanding shares 178424000 (178.42 Million). Also see NU cash flow conversion for how efficiently the company converts equity into cash flow.
NeutriSci International Inc Market Cap History (2015–2026)
NeutriSci International Inc market cap history from 2015 to 2026. Data shows growth from $20.01 Million to $1.50 Billion (46.23% CAGR). Check NU stock price for real-time trading data and today's change.
NeutriSci International Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NeutriSci International Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore NU net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
10.76x
NeutriSci International Inc's market cap is 10.76 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $20.01 Million | $27.79K | -$4.01 Million | 719.78x | N/A |
| 2016 | $19.36 Million | $125.35K | -$2.56 Million | 154.45x | N/A |
| 2017 | $34.20 Million | $151.07K | -$2.12 Million | 226.40x | N/A |
| 2018 | $10.33 Million | $82.66K | -$2.38 Million | 124.91x | N/A |
| 2019 | $3.23 Million | $96.54K | -$1.61 Million | 33.42x | N/A |
| 2020 | $16.78 Million | $74.57K | -$1.95 Million | 225.00x | N/A |
| 2021 | $7.10 Million | $80.89K | -$1.57 Million | 87.75x | N/A |
| 2022 | $1.94 Million | $457.75K | -$770.69K | 4.23x | N/A |
| 2023 | $645.35K | $59.98K | -$552.45K | 10.76x | N/A |
Competitor Companies of NU by Market Capitalization
Companies near NeutriSci International Inc in the global market cap rankings as of November 1, 2026. Also see NU total asset value for a full breakdown of the balance sheet.
Key companies related to NeutriSci International Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of NeutriSci International Inc (2015–2026)
Market capitalization of NeutriSci International Inc from 2015 to today. Between 2015 and today, NeutriSci International Inc's market cap moved from $20.01 Million to $ 1.50 Billion, with a yearly change of 46.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$1.50 Billion | -30.65% |
| 2025 | CA$2.16 Billion | +61.43% |
| 2024 | CA$1.34 Billion | +207300.00% |
| 2023 | CA$645.35K | -66.67% |
| 2022 | CA$1.94 Million | -72.73% |
| 2021 | CA$7.10 Million | -57.69% |
| 2020 | CA$16.78 Million | +420.00% |
| 2019 | CA$3.23 Million | -68.75% |
| 2018 | CA$10.33 Million | -69.81% |
| 2017 | CA$34.20 Million | +76.67% |
| 2016 | CA$19.36 Million | -3.23% |
| 2015 | CA$20.01 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of NeutriSci International Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $892.12K USD |
| MoneyControl | $892.12K USD |
| MarketWatch | $892.12K USD |
| marketcap.company | $892.12K USD |
| Reuters | $892.12K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NeutriSci International Inc
NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.